KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Manhattan Associates (MANH) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Manhattan Associates (MANH) over the last 16 years, with Q3 2025 value amounting to $1000.0.

  • Manhattan Associates' Gains from Investment Securities fell 8571.43% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $24000.0, marking a year-over-year decrease of 7931.03%. This contributed to the annual value of $133000.0 for FY2024, which is 33333.33% up from last year.
  • Manhattan Associates' Gains from Investment Securities amounted to $1000.0 in Q3 2025, which was down 8571.43% from -$77000.0 recorded in Q2 2025.
  • In the past 5 years, Manhattan Associates' Gains from Investment Securities ranged from a high of $376828.0 in Q2 2021 and a low of -$77000.0 during Q2 2025
  • Its 5-year average for Gains from Investment Securities is $33695.8, with a median of $2000.0 in 2021.
  • In the last 5 years, Manhattan Associates' Gains from Investment Securities surged by 1266093.33% in 2021 and then tumbled by 45000.0% in 2025.
  • Quarter analysis of 5 years shows Manhattan Associates' Gains from Investment Securities stood at $7000.0 in 2021, then soared by 885.71% to $69000.0 in 2022, then tumbled by 121.74% to -$15000.0 in 2023, then surged by 113.33% to $2000.0 in 2024, then plummeted by 50.0% to $1000.0 in 2025.
  • Its Gains from Investment Securities was $1000.0 in Q3 2025, compared to -$77000.0 in Q2 2025 and $98000.0 in Q1 2025.